BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15037971)

  • 21. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone.
    Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY
    J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration.
    Zheng MH; Fan Y; Smith A; Wysocki S; Papadimitriou JM; Wood DJ
    J Cell Biochem; 1998 Jul; 70(1):121-9. PubMed ID: 9632113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.
    Dalle Carbonare L; Valenti MT; Azzarello G; Balducci E; Crepaldi G; Realdi G; Vinante O; Giannini S
    Mol Cell Endocrinol; 2005 Aug; 240(1-2):23-31. PubMed ID: 15978718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.
    Clohisy DR; O' Keefe PF; Ramnaraine ML
    J Orthop Res; 2001 Jul; 19(4):554-8. PubMed ID: 11518261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
    Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
    Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effects of bisphosphonates.
    Green JR
    Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone.
    Lau CP; Wong KC; Huang L; Li G; Tsui SK; Kumta SM
    Connect Tissue Res; 2015 Nov; 56(6):493-503. PubMed ID: 26327464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of the stromal cell in giant cell tumor of bone.
    Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
    Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antitumor potential of bisphosphonates.
    Clézardin P
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
    Wen J; Xie D; Yao J; Zhang M; Bi J
    Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.
    Savadkoohi DG; Sadeghipour P; Attarian H; Sardari S; Eslamifar A; Shokrgozar MA
    J Bone Joint Surg Br; 2008 Jul; 90(7):973-9. PubMed ID: 18591612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
    Lee MV; Fong EM; Singer FR; Guenette RS
    Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor potential of bisphosphonates.
    Green JR
    Med Klin (Munich); 2000 Oct; 95 Suppl 2():23-8. PubMed ID: 11089384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
    Plotkin LI; Manolagas SC; Bellido T
    Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
    Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.
    Ottewell PD; Deux B; Mönkkönen H; Cross S; Coleman RE; Clezardin P; Holen I
    Clin Cancer Res; 2008 Jul; 14(14):4658-66. PubMed ID: 18628481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.